Intel Surges Past IBM in 2026 Stock Performance as AI Foundry Bets Fuel Massive Gains

NEW YORK — Intel Corp. has dramatically outperformed International Business Machines Corp. in 2026, with shares surging more than 160% year-to-date amid a remarkable recovery driven by AI infrastructure demand and foundry partnerships, while IBM has delivered more modest gains supported by steady software and quantum computing progress.

The divergence highlights contrasting paths for two legacy tech giants navigating the artificial intelligence boom. Intel, long struggling with manufacturing challenges and competition, has rebounded sharply from 2025 lows near $19, recently trading around $100 after hitting highs above $130. IBM, trading near $290-$300, has posted solid but less explosive returns, benefiting from hybrid cloud stability and enterprise AI adoption.

Analysts present a nuanced picture. Many view IBM as the more stable long-term choice with consistent earnings and a favorable fundamental score, while Intel offers higher upside potential — and risk — tied to execution on its turnaround. Neither stock comes with a simple “buy” recommendation, as investors must weigh valuations, competitive pressures and broader semiconductor cyclicality.

Intel’s Dramatic Rebound

Intel reported first-quarter 2026 revenue of $13.6 billion, up 7% year-over-year. The company guided for second-quarter revenue between $13.8 billion and $14.8 billion. Non-GAAP earnings per share showed improvement, though GAAP results reflected ongoing restructuring costs.

Key catalysts include partnerships with Foxconn for AI infrastructure, Hitachi for collaboration, and progress on advanced process nodes like Intel 18A. The foundry business has gained traction with external customers, and products such as Panther Lake and Nova Lake position the company for potential market share recovery in PCs and servers.

Year-to-date, Intel’s performance has been exceptional, with returns exceeding 160-190% in some measures, far outpacing broader indices. Over the past year, gains have approached 400%. However, recent sessions saw volatility, including an 11% drop on one day amid sector-wide chip selloffs tied to AI demand concerns.

Analyst consensus for Intel leans toward Hold, with an average price target around $73-$89, suggesting potential downside from current levels near $100. Some models highlight risks from high valuation after the rally, competition from Nvidia and AMD, and the need for sustained foundry wins. Others see long-term value if manufacturing goals are met.

IBM’s Steady Enterprise Focus

IBM has emphasized software, consulting and hybrid cloud, with AI initiatives like Watsonx driving bookings. The company continues heavy investment in quantum computing, announcing plans for over $10 billion in the technology over five years, which has boosted sentiment.

First-quarter results showed resilience, though some quarters highlighted mixed dynamics between hardware strength and softer software/consulting growth. Shares have risen modestly year-to-date, with stronger performance in recent sessions amid positive analyst notes.

Consensus for IBM is generally Buy or Moderate Buy, with average price targets in the $290-$304 range and highs reaching $350-$375. Analysts cite stable growth, margin expansion potential and quantum optionality as positives. Valuation trades at a premium but is supported by predictable cash flows and dividends.

Head-to-Head Comparison

Comparisons favor IBM on several fundamental metrics, including stronger long-term buy signals, better financial health scores and lower volatility in some assessments. IBM often outperforms on consistency, while Intel excels in momentum during AI tailwinds.

Intel’s risk profile is higher due to manufacturing execution risks and cyclical exposure. IBM benefits from diversified revenue and enterprise stickiness. Both companies face AI disruption opportunities and challenges: Intel in chips and foundry, IBM in software and quantum.

Valuation remains a key differentiator. Intel’s post-rally multiples have drawn caution from some observers, while IBM’s steadier profile appeals to conservative investors. Dividend yields and capital return policies also factor into decisions, with both maintaining shareholder payouts.

Market Context and Risks

The 2026 tech landscape is defined by massive AI capital expenditures from hyperscalers, creating opportunities for both companies. Intel aims to capture foundry and CPU share, while IBM leverages its consulting expertise for AI deployment.

Broader risks include geopolitical tensions affecting supply chains, potential slowdowns in AI spending, and macroeconomic factors like interest rates. Intel’s turnaround depends on yield improvements and customer wins; IBM must accelerate software growth amid AI automation concerns.

Recent news underscores momentum: Intel’s collaborations at events like Computex and IBM’s quantum and cloud partnerships. However, sector rotations and earnings misses can trigger sharp moves, as seen in recent volatility.

Investment Considerations

Neither stock is a guaranteed winner. Investors bullish on semiconductor recovery and U.S. manufacturing may favor Intel for asymmetric upside, accepting higher volatility. Those seeking stability, dividends and enterprise exposure might prefer IBM.

Diversification remains key. Many portfolio managers recommend evaluating both within a broader tech allocation, monitoring quarterly execution closely. Long-term horizons favor companies demonstrating AI relevance, but near-term valuation and risks demand caution.

Analysts stress that past performance, including Intel’s 2026 surge, does not guarantee future results. Thorough due diligence, including review of SEC filings and earnings calls, is essential. This is not investment advice; individual circumstances vary.

Looking Ahead

As 2026 progresses, focus shifts to second-half product ramps for Intel and IBM’s quantum and AI commercialization milestones. The winner in the “which to buy” debate will likely depend on execution amid evolving AI demand.

Intel’s turnaround story captivates growth investors, while IBM appeals to value-oriented ones seeking reliability. Both remain central to the tech ecosystem, with potential to reward patient shareholders if strategic bets pay off.